COVID-19
Diagnostics & testing

COVID-19 test directory & pipeline

We are tracking the current status of SARS-CoV-2 tests commercialized and in development.

For immunoassays and molecular tests for COVID-19, we have compiled a fully searchable directory that includes performance data (sensitivity and specificity).

More information

 

 

Current testing situation worldwide

Our interactive map tracks the number of SARS-CoV-2 tests reported to have been performed in each country.

INTERACTIVE SARS-CoV-2 TEST-TRACKER

Country testing policies

This dashboard provides a global snapshot of COVID-19 country testing policies based on publicly available data and documents.

Read More

 

Genomic surveillance

Genomic surveillance is being increasingly used for SARS-CoV-2 to track and monitor the spread of variants and inform public health action.

READ MORE

The ACT-Accelerator

FIND is co-leading the Diagnostics Pillar of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking collaboration to reduce death and severe disease through the accelerated development, equitable allocation, and scaled up delivery of COVID-19 tests, treatments, and vaccines, thereby protecting health systems and restoring societies and economies.

Learn more about the act-accelerator

FIND evaluations of SARS-CoV-2 assays

We are conducting independent evaluations of molecular tests and immunoassays, in collaboration with WHO and multiple partners worldwide, to assist in-country decision making.

evaluations & results

Antigen rapid test implementation

FIND resources to support implementation of antigen rapid tests in your country.

READ MORE

Online courses

Join our courses to get the latest recommendations on COVID-19 testing and up-to-date information on the performance of tests and how best to deploy them.

READ MORE

Advocacy

COVID-19 has exposed how sustained underinvestment in testing has a negative impact on health, societies and economies. Managing the pandemic and building back better must put testing at the centre.

READ MORE

Investment

US$9 billion is needed to ensure equitable access to new and existing tests, including the procurement and distribution of at least 900 million molecular and antigen rapid tests.

READ MORE

Progress

Testing is the first line of defence against COVID-19. The ACT-Accelerator Diagnostics Pillar has established an ambitious agenda, aiming to achieve 10 key milestones across four workstreams by the end of 2020.

READ MORE

COVID-19 diagnostics resources

FIND documents dramatic reduction in COVID-19 testing
Read more
Toolkit for testing methodologies, strategies and setting up laboratories
Read more
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
Read more
Use of antigen-detection rapid diagnostic testing
Read more
Our shared agenda for global action to build back better
Read more
SARS-CoV-2 variants
Read more
Developing a collaborative research agenda for SARS-CoV-2 antigen rapid diagnostic tests
Read more
Framework for the governance of personal data for the Access to COVID-19 Tools Accelerator
Read more
SARS-CoV-2 antigen-detecting rapid diagnostic tests: an implementation guide
Read more
Antigen RDTs: training package
Read more
Antigen RDTs: country implementation support
Read more
ACT-Accelerator Diagnostics Pillar: No one is safe until everyone is safe
Read more
FAQs from test manufacturers
Read more
Summary of WHO COVID AG RDT Guidance
Read more
In-house test development for molecular detection of SARS-CoV-2 (En, Fr, Por)
Read more
Rapid Diagnostic Tests for Covid-19
Read more
COVID-19 in-vitro diagnostic medical devices
Read more
Access to COVID-19 Tools (ACT) Accelerator
Read more
Diagnostics for Covid-19 (Eng & Fr)
Read more
SARS-CoV-2 diagnostic use cases
Read more

Media & Press

SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations
Read more
Letter: Diagnostics solidarity is best early warning system
Read more
How scientists in Botswana discovered omicron: a look at diagnostics in LMICs
Read more
Lutter contre les inégalités d’accès aux vaccins
Read more
FIND documents dramatic reduction in COVID-19 testing
Read more
Multi-pathogen testing is the future of diagnostics
Read more
World leaders urged to make firm commitments at Second Global COVID-19 Summit by ACT-Accelerator agency leads
Read more
As poor nations seek Covid pills, officials fear repeat of AIDS crisis
Read more
FIND $7M funding for SARS-CoV-2 self-tests aims to enable more equitable distribution to LMICs
Read more
The pandemic set off a boom in diagnostics
Read more
Testing and COVID-19
Read more
ACT-Accelerator calls for fair share-based financing of US$ 23 billion to end pandemic as global emergency in 2022
Read more
Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
Read more
Opinion: what COVID-19 has taught us about the importance of testing
Read more
COVID testing equity: a reflection based on 1.5 years in the ACT-Accelerator
Read more
There will be another variant. Here’s what the world can do now
Read more
Why aren’t all countries self-testing for COVID-19?
Read more
The silent and dangerous inequity around access to COVID-19 testing: A call to action
Read more
Variant Omicron : les outils de diagnostic toujours actifs
Read more
Will Rapid Antigen Tests Detect SARS-CoV-2 With Omicron Variant? They Should
Read more
India spotlight: Investing in diagnostics for a resilient health system
Read more
Covid-19 : un plan de 50 millions de dollars d’UNITAID pour le dépistage et les traitements en faveur des pays en développement
Read more
New ACT-Accelerator strategy calls for US$ 23.4 billion international investment to solve inequities in global access to COVID-19 vaccines, tests & treatments
Read more
ACT-Accelerator partnership welcomes leadership and commitments at US COVID Summit to ending COVID-19 pandemic through equitable access to tests, treatments, and vaccines
Read more
WHO provides support around the world to bring the COVID-19 pandemic under control through vaccines and other critical measures
Read more
Vaccines alone won’t defeat the variants
Read more
COVID-19: why we can’t use antibody tests to show that vaccines are working
Read more
ACT-Accelerator launches urgent US$ 7.7 billion appeal to stem surge of dangerous variants and save lives everywhere
Read more
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
Read more
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis
Read more
Covid-19 : au Sénégal, des tests de diagnostic rapide pour tenter d’endiguer la troisième vague
Read more
Report on Assessing the Use of Digital Tools for COVID-19 Management Launched
Read more
Wild U.S. deer found with coronavirus antibodies
Read more
Global agencies sign tech transfer deals to boost COVID testing in Africa, Latam
Read more
Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians
Read more
Help wanted: digital innovations to bridge diagnostic gaps
Read more
SARS-CoV-2 rapid diagnostic tests for emerging variants
Read more
G20 Health Working Group conducts final meeting
Read more
How COVID-19 is revolutionizing health care around the world
Read more
Council on the Economics of Health For All issues brief on equitable health innovation
Read more
The governance of personal data for COVID-19 response: perspective from the Access to COVID-19 Tools Accelerator
Read more
G20 leaders boost support of the Access to COVID-19 Tools (ACT) Accelerator but urgent and immediate action is needed to maintain momentum
Read more
Disappointment brews amid fears major health summit will fail to plug gaps in global Covid response
Read more
Failure of political leadership – and imagination – is holding back the Covid-19 recovery
Read more
Covid-19 could be the last pandemic – if we invest in testing now
Read more
Los millones de vidas que ha costado no combatir unidos la covid-19
Read more
ACT-Accelerator one year on
Read more
One year into the Covid-19 pandemic, testing is as vital as ever
Read more
Fresh warning from COVID-19 solutions group, one year on
Read more
Vaccins, traitements, tests : l’écart entre pays riches et pays pauvres risque de prolonger la pandémie de Covid-19
Read more
COVAX reaches over 100 economies, 42 days after first international delivery
Read more
Global Fund thanks the United States for US$3.5 billion emergency investment to fight COVID-19
Read more
$5 COVID test, DIY-style, may be on the way
Read more
Can mass self-testing for Covid-19 keep schools safe?
Read more
Why the rich world cannot afford to leave the poor behind on vaccines
Read more
COVID-19 test makers are adapting for variants
Read more
Rapid coronavirus tests: a guide for the perplexed
Read more
SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
Read more
Millions of low-cost diagnostic tests to be made available to poorest nations
Read more
Aruba first government to join the CommonTrust Network
Read more
Behind the Covid-19 vaccine is a hidden arsenal of diagnostic tests
Read more
Time to tap Covid-19 innovations & systems to reimagine TB care
Read more
Covid-19 tests that give results in minutes to be rolled out across world
Read more
Decentralized HCV testing is key to finding the missing millions
Read more
Rapid, affordable, high quality COVID tests still scant
Read more
The breakthrough that could halt the pandemic, even before a vaccine
Read more
Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic
Read more
Rapid COVID-19 testing breaks free from the lab
Read more
Saving lives from COVID-19 is everyone’s responsibility
Read more
Where is the money for COVID-19 diagnostics?
Read more
‘The biggest monster’ is spreading. And it’s not the coronavirus.
Read more
Jeremy Hunt's clash with Whitty puts testing regime under the spotlight
Read more
Opinion: To enable UHC, close COVID-19 testing and gender gaps
Read more
How to cap the virus in the current situation: cast the testing net wider and act fast on the data
Read more
Three questions (Catharina Boehme)
Read more
WHO seeks $6B diagnostics support for unrelenting COVID-19 pandemic
Read more
Dr Tom Frieden: 'Blaming CDC for US Covid failures is like blaming someone encased in concrete for failing to swim'
Read more
Care in the time of COVID-19
Read more
'Global Goal: Unite for Our Future,’ Global Citizen and the European Commission mobilize $1.5 billion in cash grants, and $5.4 billion in loans and guarantees—for a total of $6.9 billion pledged—to combat the disproportionate impact of Covid-19 on vulnerable and disadvantaged communities
Read more
Developing countries face diagnostic challenges as the COVID-19 pandemic surges
Read more
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Read more
Women leaders unite to push for testing to exit COVID-19
Read more
UK R&D funding goes global
Read more
How Reliable Are COVID-19 Tests?
Read more
Who are the key players in making COVID-19 tests, treatments, and vaccines available to everyone?
Read more
Testing funds shortfall imperils Covid-19 fight, health groups warn
Read more
India needs to ensure that testing is at the heart of its response to Covid-19
Read more
Beset by COVID-19 pandemic, Europe searches for right test mix for diagnosis, surveillance
Read more
Diagnostic testing for severe acute respiratory syndrome–related Coronavirus-2: A narrative review
Read more
Is there still a case for testing contacts?
Read more
'Global goal: unite for our future': we're calling on the world to make sure everyone can beat COVID-19
Read more
La grande foire aux tests sérologiques
Read more
Global TB community must unite – 1.4 million lives are at stake
Read more
Dockyard : All about COVID-19 tests
Read more
How COVID-19 testing works
Read more
What African nations are teaching the West about fighting the coronavirus
Read more
Why the accuracy of SARS-CoV-2 antibody tests vary so much
Read more
First batch of Covid-19 test kits funded by Pepsico arrive at sites across India
Read more
PepsiCo India-funded COVID-19 testing kits start reaching laboratories
Read more
Demand for coronavirus tests raises concerns over HIV and malaria
Read more
Testing times – Letters to the Editor
Read more
Senegal working on $1 testing kit for Covid-19, say reports as number of cases in Africa cross 22,000
Read more
We must never forget TB is still out there
Read more
Q&A on COVID-19 antibody tests
Read more
Mologic launches manufacturing facility to boost access to COVID-19 rapid diagnostic tests
Read more
Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers
Read more
Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic
Read more
UK ‘key’ funder of Covid-19 tests in developing nations
Read more
Ramping up diagnostics in resource-poor countries
Read more
Testing the tests: Which COVID-19 tests are most accurate?
Read more
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Read more
In scramble for coronavirus supplies, rich countries push poor aside
Read more
South Korea’s factories stretched to limit churning out virus test
Read more
This is no time for ‘America First.’ China’s coronavirus tests are good enough for the U.S.
Read more
PepsiCo India commits over 5 million meals and 25,000 COVID-19 testing kits
Read more
GlobalData: Rapid POC tests to accelerate testing capacity for diagnosing COVID-19
Read more
How do coronavirus tests work?
Read more
What coronavirus tests does the world need to track the pandemic? | Free to read
Read more
'Absolutely wrong': how UK's coronavirus test strategy unravelled
Read more
New testing kits could turn tide against coronavirus-if they work
Read more
Just 2,000 key NHS staff have been tested, UK government admits
Read more
Esto es lo que sabemos de las pruebas rápidas para detectar COVID-19
Read more
A look at COVID-19 testing and why country-wide is impossible right now
Read more
New Tests Could Turn Tide Against Coronavirus—If They Work
Read more
25,000 tests a day in UK ‘not going to be adequate’ – FIND’s Dr Rangarajan Sampath
Read more
Why the U.S. coronavirus testing failures were inevitable
Read more
Catharina Boehme: «Il y a une crise évidente dans la disponibilité des tests du coronavirus»
Read more
AIDS, TB and malaria: Coronavirus threatens the endgame
Read more
Many will say globalisation got us into this mess. In reality, it is what will get us out of it
Read more
UK Government invests $28M in FIND to support SARS-CoV-2 test development
Read more
Trump’s faulty testing claims
Read more
U.K. trials coronavirus-immunity tests for home use
Read more
Q&A: FIND's Cassandra Kelly-Cirino discusses COVID-19 diagnostics pipelines
Read more
Des tests sérologiques déployés sous peu pour voir l'étendue réelle du Covid-19 en Suisse
Read more
Fast, portable tests come online to curb coronavirus pandemic
Read more
Biden, Trump wrong about WHO coronavirus tests
Read more
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Read more
Let’s worry about diagnostic capacity, not just during outbreaks
Read more
On stigma and outbreak response
Read more